Location: New York, NY
CIK: 0001773195 · Show all filings
Period: Q3 2023 (← Previous) (Next →)
Filing Date: Nov 14, 2023
Total Value: $356M (95.4% shares, 4.6% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| APGE | APOGEE THERAPEUTICS INC | 1,045,110 | $22.26M | 6.3% | $22.03 | 0.0% | COM | 03770N101 |
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 2,000,000 | $20.4M | 5.7% | $8.06 | — | SPONSORED ADS | 881624209 |
| — | CYMABAY THERAPEUTICS INC | 1,129,376 | $16.84M | 4.7% | $4.13 | — | COM | 23257D103 |
| — | BRIDGEBIO PHARMA INC | 17,000,000 | $16.41M | 4.6% | $0.81 | — | NOTE 2.500% 3/1 | 10806XAB8 |
| — | CEREVEL THERAPEUTICS HLDNG I | 685,061 | $14.95M | 4.2% | $27.97 | — | COM | 15678U128 |
| ACLX | ARCELLX INC | 400,000 | $14.35M | 4.0% | $26.17 | +31.7% | COMMON STOCK | 03940C100 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 450,000 | $13.38M | 3.8% | $20.61 | 0.0% | COM | 22663K107 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 85,000 | $12.41M | 3.5% | $127.76 | +47.3% | COM | 558868105 |
| ESTA | ESTABLISHMENT LABS HLDGS INC | 239,108 | $11.73M | 3.3% | $65.47 | -8.7% | COM | G31249108 |
| IMVT | IMMUNOVANT INC | 300,000 | $11.52M | 3.2% | $19.18 | +17.9% | COM | 45258J102 |
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 1,100,000 | $11.22M | 3.2% | $8.06 | — | Call | 881624209 |
| XENE | XENON PHARMACEUTICALS INC | 300,438 | $10.26M | 2.9% | $37.25 | +0.4% | COM | 98420N105 |
| KURA | KURA ONCOLOGY INC | 856,535 | $7.812M | 2.2% | $15.32 | -33.7% | COM | 50127T109 |
| — | ASTRIA THERAPEUTICS INC | 1,000,300 | $7.462M | 2.1% | $9.07 | — | COM | 04635X102 |
| ARKG | ARK ETF TR | 250,000 | $6.965M | 2.0% | — | — | Put | 00214Q302 |
| ESTA | ESTABLISHMENT LABS HLDGS INC | 140,000 | $6.87M | 1.9% | $65.47 | -8.7% | Call | G31249108 |
| CYTK | CYTOKINETICS INC | 230,366 | $6.787M | 1.9% | $38.37 | -13.2% | COM NEW | 23282W605 |
| KRYS | KRYSTAL BIOTECH INC | 57,500 | $6.67M | 1.9% | $122.00 | 0.0% | COM | 501147102 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 1,018,091 | $6.587M | 1.9% | $4.53 | — | SPONSORED ADS | 152309100 |
| — | MORPHIC HLDG INC | 270,000 | $6.186M | 1.7% | $39.44 | — | COM | 61775R105 |
| — | VERONA PHARMA PLC | 368,329 | $6.004M | 1.7% | $13.28 | — | SPONSORED ADS | 925050106 |
| — | INOZYME PHARMA INC | 1,379,852 | $5.795M | 1.6% | $3.34 | — | COM | 45790W108 |
| ALKS | ALKERMES PLC | 200,000 | $5.602M | 1.6% | $29.32 | 0.0% | Call | G01767105 |
| APLS | APELLIS PHARMACEUTICALS INC | 130,000 | $4.945M | 1.4% | $47.37 | -7.3% | Put | 03753U106 |
| IMVT | IMMUNOVANT INC | 128,100 | $4.918M | 1.4% | $19.18 | +17.9% | Put | 45258J102 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 1,992,466 | $4.642M | 1.3% | $2.37 | — | SPON ADS | 05280R100 |
| SVRA | SAVARA INC | 1,150,000 | $4.347M | 1.2% | $3.56 | 0.0% | COM | 805111101 |
| ASND | ASCENDIS PHARMA A/S | 46,400 | $4.345M | 1.2% | $108.03 | — | SPONSORED ADR | 04351P101 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 150,000 | $4.128M | 1.2% | $32.53 | -3.6% | COM NEW | 15117B202 |
| AZN | ASTRAZENECA PLC | 60,000 | $4.063M | 1.1% | $61.36 | — | SPONSORED ADR | 046353108 |
| TNGX | TANGO THERAPEUTICS INC | 350,000 | $3.941M | 1.1% | $6.10 | 0.0% | COM | 87583X109 |
| PRTA | PROTHENA CORP PLC | 79,214 | $3.822M | 1.1% | $64.50 | -7.9% | SHS | G72800108 |
| VKTX | VIKING THERAPEUTICS INC | 332,600 | $3.682M | 1.0% | $6.55 | +118.3% | Put | 92686J106 |
| — | MERSANA THERAPEUTICS INC | 2,850,000 | $3.619M | 1.0% | $1.27 | — | COM | 59045L106 |
| VKTX | VIKING THERAPEUTICS INC | 300,000 | $3.321M | 0.9% | $6.55 | +118.3% | COM | 92686J106 |
| SYRE | AEGLEA BIOTHERAPEUTICS INC | 242,297 | $2.968M | 0.8% | $13.22 | 0.0% | COM NEW | 00773J202 |
| — | DYNAVAX TECHNOLOGIES CORP | 200,000 | $2.954M | 0.8% | $14.77 | — | COM NEW | 268158201 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 50,000 | $2.85M | 0.8% | $55.20 | 0.0% | CLASS A ORD | 61559X104 |
| ALKS | ALKERMES PLC | 100,000 | $2.801M | 0.8% | $29.32 | 0.0% | SHS | G01767105 |
| KALV | KALVISTA PHARMACEUTICALS INC | 278,292 | $2.68M | 0.8% | $9.79 | +4.4% | COM | 483497103 |
| — | MIRATI THERAPEUTICS INC | 60,426 | $2.632M | 0.7% | $43.56 | — | COM | 60468T105 |
| IMTX | IMMATICS N.V | 200,000 | $2.316M | 0.7% | $9.33 | +27.8% | SHS | N44445109 |
| NUVL | NUVALENT INC | 50,000 | $2.299M | 0.6% | $44.38 | 0.0% | COM | 670703107 |
| — | SEAGEN INC | 10,000 | $2.122M | 0.6% | $212.15 | — | COM | 81181C104 |
| LNTH | LANTHEUS HLDGS INC | 30,000 | $2.084M | 0.6% | $73.14 | 0.0% | COM | 516544103 |
| NRIX | NURIX THERAPEUTICS INC | 250,000 | $1.965M | 0.6% | $10.00 | -8.7% | COM | 67080M103 |
| ACRS | ACLARIS THERAPEUTICS INC | 260,000 | $1.781M | 0.5% | — | — | Put | 00461U105 |
| ROIV | ROIVANT SCIENCES LTD | 150,000 | $1.752M | 0.5% | $11.31 | 0.0% | SHS | G76279101 |
| TERN | TERNS PHARMACEUTICALS INC | 325,000 | $1.635M | 0.5% | $6.35 | 0.0% | COM | 880881107 |
| APLS | APELLIS PHARMACEUTICALS INC | 40,000 | $1.522M | 0.4% | $47.37 | -7.3% | COM | 03753U106 |
| PCVX | VAXCYTE INC | 25,000 | $1.274M | 0.4% | $43.78 | +12.7% | COM | 92243G108 |
| INSP | INSPIRE MED SYS INC | 6,293 | $1.249M | 0.4% | $252.20 | 0.0% | COM | 457730109 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 155,000 | $1.238M | 0.3% | — | — | Put | 30233G209 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 125,000 | $1.156M | 0.3% | $12.78 | -15.3% | ORDINARY SHARES | N62509109 |
| — | MORPHIC HLDG INC | 50,000 | $1.145M | 0.3% | $39.44 | — | Put | 61775R105 |
| — | TALARIS THERAPEUTICS INC | 400,000 | $1.124M | 0.3% | $2.92 | — | COM | 87410C104 |
| — | THESEUS PHARMACEUTICALS INC | 400,726 | $1.078M | 0.3% | $6.56 | — | COM | 88369M101 |
| MIST | MILESTONE PHARMACEUTICALS IN | 335,068 | $1.039M | 0.3% | $4.11 | -24.4% | COM | 59935V107 |
| LIANY | LIANBIO | 672,357 | $1.002M | 0.3% | $2.95 | — | SPONSORED ADS | 53000N108 |
| ADCT | ADC THERAPEUTICS SA | 1,100,000 | $987K | 0.3% | $2.62 | -49.2% | SHS | H0036K147 |
| IFRX | INFLARX NV | 325,097 | $969K | 0.3% | $4.30 | -11.5% | COM | N44821101 |
| — | SPRINGWORKS THERAPEUTICS INC | 41,581 | $961K | 0.3% | $26.22 | — | COM | 85205L107 |
| MIRM | MIRUM PHARMACEUTICALS INC | 30,000 | $948K | 0.3% | $21.52 | +27.2% | COM | 604749101 |
| TVTX | TRAVERE THERAPEUTICS INC | 100,000 | $894K | 0.3% | $14.11 | 0.0% | COM | 89422G107 |
| PODD | INSULET CORP | 5,000 | $797K | 0.2% | $223.91 | 0.0% | COM | 45784P101 |
| BBIO | BRIDGEBIO PHARMA INC | 30,000 | $791K | 0.2% | $11.66 | +143.4% | COM | 10806X102 |
| BHVN | BIOHAVEN LTD | 30,156 | $784K | 0.2% | $20.78 | 0.0% | COM | G1110E107 |
| — | AVROBIO INC | 500,000 | $770K | 0.2% | $1.54 | — | COM | 05455M100 |
| — | IMMATICS N.V | 187,204 | $663K | 0.2% | $2.88 | — | *W EXP 07/01/202 | N44445117 |
| — | 89BIO INC | 37,300 | $576K | 0.2% | — | — | Call | 282559103 |
| PBYI | PUMA BIOTECHNOLOGY INC | 202,349 | $532K | 0.1% | $3.69 | -7.7% | COM | 74587V107 |
| — | PROMIS NEUROSCIENCES INC | 265,958 | $527K | 0.1% | $1.98 | — | COM NEW | 74346M406 |
| CNTX | CONTEXT THERAPEUTICS INC | 328,817 | $497K | 0.1% | $0.90 | +25.2% | COM | 21077P108 |
| — | MESOBLAST LTD | 400,000 | $492K | 0.1% | — | — | Put | 590717104 |
| NUVB | NUVATION BIO INC | 250,000 | $335K | 0.1% | $2.02 | -17.7% | COM CL A | 67080N101 |
| BCAB | BIOATLA INC | 180,000 | $306K | 0.1% | $5.77 | -55.8% | COM | 09077B104 |
| ALDX | ALDEYRA THERAPEUTICS INC | 44,348 | $296K | 0.1% | $9.85 | -24.7% | COM | 01438T106 |
| NAMSW | NEWAMSTERDAM PHARMA COMPANY | 137,000 | $260K | 0.1% | $1.89 | — | *W EXP 11/22/202 | N62509117 |
| — | NLS PHARMACEUTICS LTD | 200,455 | $140K | 0.0% | $1.45 | — | SHS | H57830103 |
| — | ARAVIVE INC | 346,511 | $45,739 | 0.0% | $0.13 | — | COM | 03890D108 |
| RCKTW | ROCKET PHARMACEUTICALS INC | 75,000 | $7,500 | 0.0% | $0.16 | — | *W EXP 09/02/202 | 77313F114 |